Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127604411 | 12760441 | 1 | I | 20151008 | 20160907 | 20160919 | 20160919 | EXP | GB-MHRA-EYC 00144719 | GB-TEVA-692636ACC | TEVA | 69.00 | YR | F | Y | 69.85000 | KG | 20160919 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127604411 | 12760441 | 1 | PS | NITROFURANTOIN. | NITROFURANTOIN | 1 | Oral | DON'T KNOW. NORMAL DOSE FOR CYSTITIS I THINK. | U | U | 91095 | ||||||||
| 127604411 | 12760441 | 2 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | Y | U | 76052 | 10 | MG | |||||||
| 127604411 | 12760441 | 3 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 0 | ||||||||||||
| 127604411 | 12760441 | 4 | C | BECLOMETASONE DIPROPIONATE | BECLOMETHASONE DIPROPIONATE | 1 | 0 | ||||||||||||
| 127604411 | 12760441 | 5 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127604411 | 12760441 | 6 | C | COLPERMIN | 2 | 0 | |||||||||||||
| 127604411 | 12760441 | 7 | C | CELECOXIB. | CELECOXIB | 1 | 0 | ||||||||||||
| 127604411 | 12760441 | 8 | C | GAVISCON ADVANCE | POTASSIUM BICARBONATESODIUM ALGINATE | 1 | 0 | ||||||||||||
| 127604411 | 12760441 | 9 | C | RABEPRAZOLE SODIUM. | RABEPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 127604411 | 12760441 | 10 | C | TEMAZEPAM. | TEMAZEPAM | 1 | 0 | ||||||||||||
| 127604411 | 12760441 | 11 | C | TRAMADOL. | TRAMADOL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127604411 | 12760441 | 1 | Cystitis |
| 127604411 | 12760441 | 2 | Blood cholesterol increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127604411 | 12760441 | OT |
| 127604411 | 12760441 | DS |
| 127604411 | 12760441 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127604411 | 12760441 | Abdominal distension | |
| 127604411 | 12760441 | Abdominal pain | |
| 127604411 | 12760441 | Decreased appetite | |
| 127604411 | 12760441 | Drug-induced liver injury | |
| 127604411 | 12760441 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127604411 | 12760441 | 1 | 20151004 | 0 | ||
| 127604411 | 12760441 | 2 | 20160412 | 20160416 | 0 |